AustralieFrV1, PubMed, Corpus, bibRecord, 002D28

Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.

Identifieur interne : 002D28 ( PubMed/Corpus ); précédent : 002D27; suivant : 002D29

Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.

Auteurs : Jennifer Ose ; Helena Schock ; Anne Tj Nneland ; Louise Hansen ; Kim Overvad ; Laure Dossus ; Françoise Clavel-Chapelon ; Laura Baglietto ; Heiner Boeing ; Antonia Trichopolou ; Vassiliki Benetou ; Pagona Lagiou ; Giovanna Masala ; Giovanna Tagliabue ; Rosario Tumino ; Carlotta Sacerdote ; Amalia Mattiello ; H B As Bueno-De-Mesquita ; Petra H M. Peeters ; N Charlotte Onland-Moret ; Elisabete Weiderpass ; Inger T. Gram ; Soledad Sánchez ; Mireia Obon-Santacana ; Maria-José Sànchez-Pérez ; Nerea Larra Aga ; José María Huerta Casta O ; Eva Ardanaz ; Jenny Br Ndstedt ; Eva Lundin ; Annika Idahl ; Ruth C. Travis ; Kay-Tee Khaw ; Sabina Rinaldi ; Isabelle Romieu ; Melissa A. Merritt ; Marc J. Gunter ; Elio Riboli ; Rudolf Kaaks ; Renée T. Fortner

Source :

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [ 1538-7755 ] ; 2015.

RBID : pubmed:25855626

English descriptors

KwdEn :
- Adenocarcinoma, Clear Cell (blood), Adenocarcinoma, Clear Cell (etiology), Adenocarcinoma, Clear Cell (pathology), Adenocarcinoma, Mucinous (blood), Adenocarcinoma, Mucinous (etiology), Adenocarcinoma, Mucinous (pathology), Adult, Aged, Biomarkers, Tumor (blood), Case-Control Studies, Cystadenocarcinoma, Serous (blood), Cystadenocarcinoma, Serous (etiology), Cystadenocarcinoma, Serous (pathology), Endometrial Neoplasms (blood), Endometrial Neoplasms (etiology), Endometrial Neoplasms (pathology), Female, Follow-Up Studies, Humans, Inflammation (blood), Inflammation (complications), Inflammation (pathology), Inflammation Mediators (blood), Middle Aged, Neoplasm Grading, Neoplasm Invasiveness, Neoplasm Staging, Ovarian Neoplasms (blood), Ovarian Neoplasms (etiology), Ovarian Neoplasms (pathology), Prognosis, Prospective Studies.
MESH :
- chemical , blood : Biomarkers, Tumor, Inflammation Mediators.
- blood : Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Endometrial Neoplasms, Inflammation, Ovarian Neoplasms.
- complications : Inflammation.
- etiology : Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Endometrial Neoplasms, Ovarian Neoplasms.
- pathology : Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Endometrial Neoplasms, Inflammation, Ovarian Neoplasms.
- Adult, Aged, Case-Control Studies, Female, Follow-Up Studies, Humans, Middle Aged, Neoplasm Grading, Neoplasm Invasiveness, Neoplasm Staging, Prognosis, Prospective Studies.

Abstract

Evidence suggests an etiologic role for inflammation in ovarian carcinogenesis and heterogeneity between tumor subtypes and anthropometric indices. Prospective studies on circulating inflammatory markers and epithelial invasive ovarian cancer (EOC) have predominantly investigated overall risk; data characterizing risk by tumor characteristics (histology, grade, stage, dualistic model of ovarian carcinogenesis) and anthropometric indices are sparse.

DOI: 10.1158/1055-9965.EPI-14-1279-T
PubMed: 25855626

Links to Exploration step

pubmed:25855626

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.</title>
<author><name sortKey="Ose, Jennifer" sort="Ose, Jennifer" uniqKey="Ose J" first="Jennifer" last="Ose">Jennifer Ose</name>
<affiliation><nlm:affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schock, Helena" sort="Schock, Helena" uniqKey="Schock H" first="Helena" last="Schock">Helena Schock</name>
<affiliation><nlm:affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tj Nneland, Anne" sort="Tj Nneland, Anne" uniqKey="Tj Nneland A" first="Anne" last="Tj Nneland">Anne Tj Nneland</name>
<affiliation><nlm:affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hansen, Louise" sort="Hansen, Louise" uniqKey="Hansen L" first="Louise" last="Hansen">Louise Hansen</name>
<affiliation><nlm:affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Overvad, Kim" sort="Overvad, Kim" uniqKey="Overvad K" first="Kim" last="Overvad">Kim Overvad</name>
<affiliation><nlm:affiliation>Department of Public Health, Section for Epidemiology Danish Cancer, Aarhus University, Aarhus, Denmark.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dossus, Laure" sort="Dossus, Laure" uniqKey="Dossus L" first="Laure" last="Dossus">Laure Dossus</name>
<affiliation><nlm:affiliation>INSERM, Centre for Research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women's Health Team, Villejuif, France. Univ Paris Sud, UMRS 1018, Villejuif, France. IGR, Villejuif, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Clavel Chapelon, Francoise" sort="Clavel Chapelon, Francoise" uniqKey="Clavel Chapelon F" first="Françoise" last="Clavel-Chapelon">Françoise Clavel-Chapelon</name>
<affiliation><nlm:affiliation>INSERM, Centre for Research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women's Health Team, Villejuif, France. Univ Paris Sud, UMRS 1018, Villejuif, France. IGR, Villejuif, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Baglietto, Laura" sort="Baglietto, Laura" uniqKey="Baglietto L" first="Laura" last="Baglietto">Laura Baglietto</name>
<affiliation><nlm:affiliation>Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Boeing, Heiner" sort="Boeing, Heiner" uniqKey="Boeing H" first="Heiner" last="Boeing">Heiner Boeing</name>
<affiliation><nlm:affiliation>Department of Epidemiology, German Institute of Human Nutrition (DIfE) Potsdam-Rehbrücke, Nuthetal, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Trichopolou, Antonia" sort="Trichopolou, Antonia" uniqKey="Trichopolou A" first="Antonia" last="Trichopolou">Antonia Trichopolou</name>
<affiliation><nlm:affiliation>Hellenic Health Foundation, Athens, Greece. Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Benetou, Vassiliki" sort="Benetou, Vassiliki" uniqKey="Benetou V" first="Vassiliki" last="Benetou">Vassiliki Benetou</name>
<affiliation><nlm:affiliation>Hellenic Health Foundation, Athens, Greece. Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lagiou, Pagona" sort="Lagiou, Pagona" uniqKey="Lagiou P" first="Pagona" last="Lagiou">Pagona Lagiou</name>
<affiliation><nlm:affiliation>Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece. Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Masala, Giovanna" sort="Masala, Giovanna" uniqKey="Masala G" first="Giovanna" last="Masala">Giovanna Masala</name>
<affiliation><nlm:affiliation>Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tagliabue, Giovanna" sort="Tagliabue, Giovanna" uniqKey="Tagliabue G" first="Giovanna" last="Tagliabue">Giovanna Tagliabue</name>
<affiliation><nlm:affiliation>Lombardy Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tumino, Rosario" sort="Tumino, Rosario" uniqKey="Tumino R" first="Rosario" last="Tumino">Rosario Tumino</name>
<affiliation><nlm:affiliation>Cancer Registry and Histopathology Unit, "Civic - M.P. Arezzo" Hospita, ASP Ragusa, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sacerdote, Carlotta" sort="Sacerdote, Carlotta" uniqKey="Sacerdote C" first="Carlotta" last="Sacerdote">Carlotta Sacerdote</name>
<affiliation><nlm:affiliation>Center for Cancer Prevention (CPOPiemonte), Turin, Italy. Human Genetic Foundation, Torino, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mattiello, Amalia" sort="Mattiello, Amalia" uniqKey="Mattiello A" first="Amalia" last="Mattiello">Amalia Mattiello</name>
<affiliation><nlm:affiliation>Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bueno De Mesquita, H B As" sort="Bueno De Mesquita, H B As" uniqKey="Bueno De Mesquita H" first="H B As" last="Bueno-De-Mesquita">H B As Bueno-De-Mesquita</name>
<affiliation><nlm:affiliation>Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands. Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom. Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Peeters, Petra H M" sort="Peeters, Petra H M" uniqKey="Peeters P" first="Petra H M" last="Peeters">Petra H M. Peeters</name>
<affiliation><nlm:affiliation>Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Onland Moret, N Charlotte" sort="Onland Moret, N Charlotte" uniqKey="Onland Moret N" first="N Charlotte" last="Onland-Moret">N Charlotte Onland-Moret</name>
<affiliation><nlm:affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Weiderpass, Elisabete" sort="Weiderpass, Elisabete" uniqKey="Weiderpass E" first="Elisabete" last="Weiderpass">Elisabete Weiderpass</name>
<affiliation><nlm:affiliation>Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway. Cancer Registry of Norway, Oslo, Norway. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Department of Genetic Epidemiology, Folkhälsan Research Center, Helsinki, Finland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gram, Inger T" sort="Gram, Inger T" uniqKey="Gram I" first="Inger T" last="Gram">Inger T. Gram</name>
<affiliation><nlm:affiliation>Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sanchez, Soledad" sort="Sanchez, Soledad" uniqKey="Sanchez S" first="Soledad" last="Sánchez">Soledad Sánchez</name>
<affiliation><nlm:affiliation>Public Health Directorate, Asturias, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Obon Santacana, Mireia" sort="Obon Santacana, Mireia" uniqKey="Obon Santacana M" first="Mireia" last="Obon-Santacana">Mireia Obon-Santacana</name>
<affiliation><nlm:affiliation>Unit of Nutrition, Environment, and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sanchez Perez, Maria Jose" sort="Sanchez Perez, Maria Jose" uniqKey="Sanchez Perez M" first="Maria-José" last="Sànchez-Pérez">Maria-José Sànchez-Pérez</name>
<affiliation><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Andalusian School of Public Health, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Larra Aga, Nerea" sort="Larra Aga, Nerea" uniqKey="Larra Aga N" first="Nerea" last="Larra Aga">Nerea Larra Aga</name>
<affiliation><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Public Health Division of Gipuzkoa-BIODONOSTIA, Basque Regional Health Department, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Casta O, Jose Maria Huerta" sort="Casta O, Jose Maria Huerta" uniqKey="Casta O J" first="José María Huerta" last="Casta O">José María Huerta Casta O</name>
<affiliation><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ardanaz, Eva" sort="Ardanaz, Eva" uniqKey="Ardanaz E" first="Eva" last="Ardanaz">Eva Ardanaz</name>
<affiliation><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Navarre Public Health Institute, Pamplona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Br Ndstedt, Jenny" sort="Br Ndstedt, Jenny" uniqKey="Br Ndstedt J" first="Jenny" last="Br Ndstedt">Jenny Br Ndstedt</name>
<affiliation><nlm:affiliation>Department of Surgery, Skåne University Hospital, Malmö, Sweden. Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Skåne University Hospital, Lund, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lundin, Eva" sort="Lundin, Eva" uniqKey="Lundin E" first="Eva" last="Lundin">Eva Lundin</name>
<affiliation><nlm:affiliation>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Idahl, Annika" sort="Idahl, Annika" uniqKey="Idahl A" first="Annika" last="Idahl">Annika Idahl</name>
<affiliation><nlm:affiliation>Department of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden. Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Travis, Ruth C" sort="Travis, Ruth C" uniqKey="Travis R" first="Ruth C" last="Travis">Ruth C. Travis</name>
<affiliation><nlm:affiliation>Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Khaw, Kay Tee" sort="Khaw, Kay Tee" uniqKey="Khaw K" first="Kay-Tee" last="Khaw">Kay-Tee Khaw</name>
<affiliation><nlm:affiliation>Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rinaldi, Sabina" sort="Rinaldi, Sabina" uniqKey="Rinaldi S" first="Sabina" last="Rinaldi">Sabina Rinaldi</name>
<affiliation><nlm:affiliation>Biomarkers Group, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Romieu, Isabelle" sort="Romieu, Isabelle" uniqKey="Romieu I" first="Isabelle" last="Romieu">Isabelle Romieu</name>
<affiliation><nlm:affiliation>Biomarkers Group, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Merritt, Melissa A" sort="Merritt, Melissa A" uniqKey="Merritt M" first="Melissa A" last="Merritt">Melissa A. Merritt</name>
<affiliation><nlm:affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gunter, Marc J" sort="Gunter, Marc J" uniqKey="Gunter M" first="Marc J" last="Gunter">Marc J. Gunter</name>
<affiliation><nlm:affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Riboli, Elio" sort="Riboli, Elio" uniqKey="Riboli E" first="Elio" last="Riboli">Elio Riboli</name>
<affiliation><nlm:affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kaaks, Rudolf" sort="Kaaks, Rudolf" uniqKey="Kaaks R" first="Rudolf" last="Kaaks">Rudolf Kaaks</name>
<affiliation><nlm:affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fortner, Renee T" sort="Fortner, Renee T" uniqKey="Fortner R" first="Renée T" last="Fortner">Renée T. Fortner</name>
<affiliation><nlm:affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. r.fortner@dkfz-heidelberg.de.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25855626</idno>
<idno type="pmid">25855626</idno>
<idno type="doi">10.1158/1055-9965.EPI-14-1279-T</idno>
<idno type="wicri:Area/PubMed/Corpus">002D28</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D28</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.</title>
<author><name sortKey="Ose, Jennifer" sort="Ose, Jennifer" uniqKey="Ose J" first="Jennifer" last="Ose">Jennifer Ose</name>
<affiliation><nlm:affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schock, Helena" sort="Schock, Helena" uniqKey="Schock H" first="Helena" last="Schock">Helena Schock</name>
<affiliation><nlm:affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tj Nneland, Anne" sort="Tj Nneland, Anne" uniqKey="Tj Nneland A" first="Anne" last="Tj Nneland">Anne Tj Nneland</name>
<affiliation><nlm:affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hansen, Louise" sort="Hansen, Louise" uniqKey="Hansen L" first="Louise" last="Hansen">Louise Hansen</name>
<affiliation><nlm:affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Overvad, Kim" sort="Overvad, Kim" uniqKey="Overvad K" first="Kim" last="Overvad">Kim Overvad</name>
<affiliation><nlm:affiliation>Department of Public Health, Section for Epidemiology Danish Cancer, Aarhus University, Aarhus, Denmark.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dossus, Laure" sort="Dossus, Laure" uniqKey="Dossus L" first="Laure" last="Dossus">Laure Dossus</name>
<affiliation><nlm:affiliation>INSERM, Centre for Research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women's Health Team, Villejuif, France. Univ Paris Sud, UMRS 1018, Villejuif, France. IGR, Villejuif, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Clavel Chapelon, Francoise" sort="Clavel Chapelon, Francoise" uniqKey="Clavel Chapelon F" first="Françoise" last="Clavel-Chapelon">Françoise Clavel-Chapelon</name>
<affiliation><nlm:affiliation>INSERM, Centre for Research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women's Health Team, Villejuif, France. Univ Paris Sud, UMRS 1018, Villejuif, France. IGR, Villejuif, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Baglietto, Laura" sort="Baglietto, Laura" uniqKey="Baglietto L" first="Laura" last="Baglietto">Laura Baglietto</name>
<affiliation><nlm:affiliation>Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Boeing, Heiner" sort="Boeing, Heiner" uniqKey="Boeing H" first="Heiner" last="Boeing">Heiner Boeing</name>
<affiliation><nlm:affiliation>Department of Epidemiology, German Institute of Human Nutrition (DIfE) Potsdam-Rehbrücke, Nuthetal, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Trichopolou, Antonia" sort="Trichopolou, Antonia" uniqKey="Trichopolou A" first="Antonia" last="Trichopolou">Antonia Trichopolou</name>
<affiliation><nlm:affiliation>Hellenic Health Foundation, Athens, Greece. Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Benetou, Vassiliki" sort="Benetou, Vassiliki" uniqKey="Benetou V" first="Vassiliki" last="Benetou">Vassiliki Benetou</name>
<affiliation><nlm:affiliation>Hellenic Health Foundation, Athens, Greece. Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lagiou, Pagona" sort="Lagiou, Pagona" uniqKey="Lagiou P" first="Pagona" last="Lagiou">Pagona Lagiou</name>
<affiliation><nlm:affiliation>Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece. Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Masala, Giovanna" sort="Masala, Giovanna" uniqKey="Masala G" first="Giovanna" last="Masala">Giovanna Masala</name>
<affiliation><nlm:affiliation>Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tagliabue, Giovanna" sort="Tagliabue, Giovanna" uniqKey="Tagliabue G" first="Giovanna" last="Tagliabue">Giovanna Tagliabue</name>
<affiliation><nlm:affiliation>Lombardy Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tumino, Rosario" sort="Tumino, Rosario" uniqKey="Tumino R" first="Rosario" last="Tumino">Rosario Tumino</name>
<affiliation><nlm:affiliation>Cancer Registry and Histopathology Unit, "Civic - M.P. Arezzo" Hospita, ASP Ragusa, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sacerdote, Carlotta" sort="Sacerdote, Carlotta" uniqKey="Sacerdote C" first="Carlotta" last="Sacerdote">Carlotta Sacerdote</name>
<affiliation><nlm:affiliation>Center for Cancer Prevention (CPOPiemonte), Turin, Italy. Human Genetic Foundation, Torino, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mattiello, Amalia" sort="Mattiello, Amalia" uniqKey="Mattiello A" first="Amalia" last="Mattiello">Amalia Mattiello</name>
<affiliation><nlm:affiliation>Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bueno De Mesquita, H B As" sort="Bueno De Mesquita, H B As" uniqKey="Bueno De Mesquita H" first="H B As" last="Bueno-De-Mesquita">H B As Bueno-De-Mesquita</name>
<affiliation><nlm:affiliation>Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands. Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom. Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Peeters, Petra H M" sort="Peeters, Petra H M" uniqKey="Peeters P" first="Petra H M" last="Peeters">Petra H M. Peeters</name>
<affiliation><nlm:affiliation>Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Onland Moret, N Charlotte" sort="Onland Moret, N Charlotte" uniqKey="Onland Moret N" first="N Charlotte" last="Onland-Moret">N Charlotte Onland-Moret</name>
<affiliation><nlm:affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Weiderpass, Elisabete" sort="Weiderpass, Elisabete" uniqKey="Weiderpass E" first="Elisabete" last="Weiderpass">Elisabete Weiderpass</name>
<affiliation><nlm:affiliation>Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway. Cancer Registry of Norway, Oslo, Norway. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Department of Genetic Epidemiology, Folkhälsan Research Center, Helsinki, Finland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gram, Inger T" sort="Gram, Inger T" uniqKey="Gram I" first="Inger T" last="Gram">Inger T. Gram</name>
<affiliation><nlm:affiliation>Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sanchez, Soledad" sort="Sanchez, Soledad" uniqKey="Sanchez S" first="Soledad" last="Sánchez">Soledad Sánchez</name>
<affiliation><nlm:affiliation>Public Health Directorate, Asturias, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Obon Santacana, Mireia" sort="Obon Santacana, Mireia" uniqKey="Obon Santacana M" first="Mireia" last="Obon-Santacana">Mireia Obon-Santacana</name>
<affiliation><nlm:affiliation>Unit of Nutrition, Environment, and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sanchez Perez, Maria Jose" sort="Sanchez Perez, Maria Jose" uniqKey="Sanchez Perez M" first="Maria-José" last="Sànchez-Pérez">Maria-José Sànchez-Pérez</name>
<affiliation><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Andalusian School of Public Health, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Larra Aga, Nerea" sort="Larra Aga, Nerea" uniqKey="Larra Aga N" first="Nerea" last="Larra Aga">Nerea Larra Aga</name>
<affiliation><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Public Health Division of Gipuzkoa-BIODONOSTIA, Basque Regional Health Department, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Casta O, Jose Maria Huerta" sort="Casta O, Jose Maria Huerta" uniqKey="Casta O J" first="José María Huerta" last="Casta O">José María Huerta Casta O</name>
<affiliation><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ardanaz, Eva" sort="Ardanaz, Eva" uniqKey="Ardanaz E" first="Eva" last="Ardanaz">Eva Ardanaz</name>
<affiliation><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Navarre Public Health Institute, Pamplona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Br Ndstedt, Jenny" sort="Br Ndstedt, Jenny" uniqKey="Br Ndstedt J" first="Jenny" last="Br Ndstedt">Jenny Br Ndstedt</name>
<affiliation><nlm:affiliation>Department of Surgery, Skåne University Hospital, Malmö, Sweden. Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Skåne University Hospital, Lund, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lundin, Eva" sort="Lundin, Eva" uniqKey="Lundin E" first="Eva" last="Lundin">Eva Lundin</name>
<affiliation><nlm:affiliation>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Idahl, Annika" sort="Idahl, Annika" uniqKey="Idahl A" first="Annika" last="Idahl">Annika Idahl</name>
<affiliation><nlm:affiliation>Department of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden. Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Travis, Ruth C" sort="Travis, Ruth C" uniqKey="Travis R" first="Ruth C" last="Travis">Ruth C. Travis</name>
<affiliation><nlm:affiliation>Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Khaw, Kay Tee" sort="Khaw, Kay Tee" uniqKey="Khaw K" first="Kay-Tee" last="Khaw">Kay-Tee Khaw</name>
<affiliation><nlm:affiliation>Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rinaldi, Sabina" sort="Rinaldi, Sabina" uniqKey="Rinaldi S" first="Sabina" last="Rinaldi">Sabina Rinaldi</name>
<affiliation><nlm:affiliation>Biomarkers Group, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Romieu, Isabelle" sort="Romieu, Isabelle" uniqKey="Romieu I" first="Isabelle" last="Romieu">Isabelle Romieu</name>
<affiliation><nlm:affiliation>Biomarkers Group, International Agency for Research on Cancer, Lyon, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Merritt, Melissa A" sort="Merritt, Melissa A" uniqKey="Merritt M" first="Melissa A" last="Merritt">Melissa A. Merritt</name>
<affiliation><nlm:affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gunter, Marc J" sort="Gunter, Marc J" uniqKey="Gunter M" first="Marc J" last="Gunter">Marc J. Gunter</name>
<affiliation><nlm:affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Riboli, Elio" sort="Riboli, Elio" uniqKey="Riboli E" first="Elio" last="Riboli">Elio Riboli</name>
<affiliation><nlm:affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kaaks, Rudolf" sort="Kaaks, Rudolf" uniqKey="Kaaks R" first="Rudolf" last="Kaaks">Rudolf Kaaks</name>
<affiliation><nlm:affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fortner, Renee T" sort="Fortner, Renee T" uniqKey="Fortner R" first="Renée T" last="Fortner">Renée T. Fortner</name>
<affiliation><nlm:affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. r.fortner@dkfz-heidelberg.de.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</title>
<idno type="eISSN">1538-7755</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma, Clear Cell (blood)</term>
<term>Adenocarcinoma, Clear Cell (etiology)</term>
<term>Adenocarcinoma, Clear Cell (pathology)</term>
<term>Adenocarcinoma, Mucinous (blood)</term>
<term>Adenocarcinoma, Mucinous (etiology)</term>
<term>Adenocarcinoma, Mucinous (pathology)</term>
<term>Adult</term>
<term>Aged</term>
<term>Biomarkers, Tumor (blood)</term>
<term>Case-Control Studies</term>
<term>Cystadenocarcinoma, Serous (blood)</term>
<term>Cystadenocarcinoma, Serous (etiology)</term>
<term>Cystadenocarcinoma, Serous (pathology)</term>
<term>Endometrial Neoplasms (blood)</term>
<term>Endometrial Neoplasms (etiology)</term>
<term>Endometrial Neoplasms (pathology)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Inflammation (blood)</term>
<term>Inflammation (complications)</term>
<term>Inflammation (pathology)</term>
<term>Inflammation Mediators (blood)</term>
<term>Middle Aged</term>
<term>Neoplasm Grading</term>
<term>Neoplasm Invasiveness</term>
<term>Neoplasm Staging</term>
<term>Ovarian Neoplasms (blood)</term>
<term>Ovarian Neoplasms (etiology)</term>
<term>Ovarian Neoplasms (pathology)</term>
<term>Prognosis</term>
<term>Prospective Studies</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Biomarkers, Tumor</term>
<term>Inflammation Mediators</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Adenocarcinoma, Clear Cell</term>
<term>Adenocarcinoma, Mucinous</term>
<term>Cystadenocarcinoma, Serous</term>
<term>Endometrial Neoplasms</term>
<term>Inflammation</term>
<term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Inflammation</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Adenocarcinoma, Clear Cell</term>
<term>Adenocarcinoma, Mucinous</term>
<term>Cystadenocarcinoma, Serous</term>
<term>Endometrial Neoplasms</term>
<term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma, Clear Cell</term>
<term>Adenocarcinoma, Mucinous</term>
<term>Cystadenocarcinoma, Serous</term>
<term>Endometrial Neoplasms</term>
<term>Inflammation</term>
<term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Case-Control Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Neoplasm Grading</term>
<term>Neoplasm Invasiveness</term>
<term>Neoplasm Staging</term>
<term>Prognosis</term>
<term>Prospective Studies</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Evidence suggests an etiologic role for inflammation in ovarian carcinogenesis and heterogeneity between tumor subtypes and anthropometric indices. Prospective studies on circulating inflammatory markers and epithelial invasive ovarian cancer (EOC) have predominantly investigated overall risk; data characterizing risk by tumor characteristics (histology, grade, stage, dualistic model of ovarian carcinogenesis) and anthropometric indices are sparse.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25855626</PMID>
<DateCreated><Year>2015</Year>
<Month>06</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>02</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>09</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7755</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>24</Volume>
<Issue>6</Issue>
<PubDate><Year>2015</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</Title>
<ISOAbbreviation>Cancer Epidemiol. Biomarkers Prev.</ISOAbbreviation>
</Journal>
<ArticleTitle>Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.</ArticleTitle>
<Pagination><MedlinePgn>951-61</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1158/1055-9965.EPI-14-1279-T</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Evidence suggests an etiologic role for inflammation in ovarian carcinogenesis and heterogeneity between tumor subtypes and anthropometric indices. Prospective studies on circulating inflammatory markers and epithelial invasive ovarian cancer (EOC) have predominantly investigated overall risk; data characterizing risk by tumor characteristics (histology, grade, stage, dualistic model of ovarian carcinogenesis) and anthropometric indices are sparse.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort to evaluate C-reactive protein (CRP), IL6, and EOC risk by tumor characteristics. A total of 754 eligible EOC cases were identified; two controls (n = 1,497) were matched per case. We used multivariable conditional logistic regression to assess associations.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">CRP and IL6 were not associated with overall EOC risk. However, consistent with prior research, CRP >10 versus CRP ≤1 mg/L was associated with higher overall EOC risk [OR, 1.67 (1.03-2.70)]. We did not observe significant associations or heterogeneity in analyses by tumor characteristics. In analyses stratified by waist circumference, inflammatory markers were associated with higher risk among women with higher waist circumference; no association was observed for women with normal waist circumference [e.g., IL6: waist ≤80: ORlog2, 0.97 (0.81-1.16); waist >88: ORlog2, 1.78 (1.28-2.48), Pheterogeneity ≤ 0.01].</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our data suggest that high CRP is associated with increased risk of overall EOC, and that IL6 and CRP may be associated with EOC risk among women with higher adiposity.</AbstractText>
<AbstractText Label="IMPACT" NlmCategory="CONCLUSIONS">Our data add to global evidence that ovarian carcinogenesis may be promoted by an inflammatory milieu.</AbstractText>
<CopyrightInformation>©2015 American Association for Cancer Research.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ose</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schock</LastName>
<ForeName>Helena</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tjønneland</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hansen</LastName>
<ForeName>Louise</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Overvad</LastName>
<ForeName>Kim</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Department of Public Health, Section for Epidemiology Danish Cancer, Aarhus University, Aarhus, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dossus</LastName>
<ForeName>Laure</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>INSERM, Centre for Research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women's Health Team, Villejuif, France. Univ Paris Sud, UMRS 1018, Villejuif, France. IGR, Villejuif, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Clavel-Chapelon</LastName>
<ForeName>Françoise</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>INSERM, Centre for Research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women's Health Team, Villejuif, France. Univ Paris Sud, UMRS 1018, Villejuif, France. IGR, Villejuif, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Baglietto</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Boeing</LastName>
<ForeName>Heiner</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Department of Epidemiology, German Institute of Human Nutrition (DIfE) Potsdam-Rehbrücke, Nuthetal, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Trichopolou</LastName>
<ForeName>Antonia</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Hellenic Health Foundation, Athens, Greece. Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Benetou</LastName>
<ForeName>Vassiliki</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Hellenic Health Foundation, Athens, Greece. Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lagiou</LastName>
<ForeName>Pagona</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece. Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Masala</LastName>
<ForeName>Giovanna</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tagliabue</LastName>
<ForeName>Giovanna</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Lombardy Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tumino</LastName>
<ForeName>Rosario</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Cancer Registry and Histopathology Unit, "Civic - M.P. Arezzo" Hospita, ASP Ragusa, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sacerdote</LastName>
<ForeName>Carlotta</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Center for Cancer Prevention (CPOPiemonte), Turin, Italy. Human Genetic Foundation, Torino, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mattiello</LastName>
<ForeName>Amalia</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bueno-de-Mesquita</LastName>
<ForeName>H B As</ForeName>
<Initials>HB</Initials>
<AffiliationInfo><Affiliation>Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands. Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom. Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Peeters</LastName>
<ForeName>Petra H M</ForeName>
<Initials>PH</Initials>
<AffiliationInfo><Affiliation>Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Onland-Moret</LastName>
<ForeName>N Charlotte</ForeName>
<Initials>NC</Initials>
<AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Weiderpass</LastName>
<ForeName>Elisabete</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway. Cancer Registry of Norway, Oslo, Norway. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Department of Genetic Epidemiology, Folkhälsan Research Center, Helsinki, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gram</LastName>
<ForeName>Inger T</ForeName>
<Initials>IT</Initials>
<AffiliationInfo><Affiliation>Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sánchez</LastName>
<ForeName>Soledad</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Public Health Directorate, Asturias, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Obon-Santacana</LastName>
<ForeName>Mireia</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Unit of Nutrition, Environment, and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sànchez-Pérez</LastName>
<ForeName>Maria-José</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Andalusian School of Public Health, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Larrañaga</LastName>
<ForeName>Nerea</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Public Health Division of Gipuzkoa-BIODONOSTIA, Basque Regional Health Department, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Castaño</LastName>
<ForeName>José María Huerta</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ardanaz</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Navarre Public Health Institute, Pamplona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Brändstedt</LastName>
<ForeName>Jenny</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Surgery, Skåne University Hospital, Malmö, Sweden. Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Skåne University Hospital, Lund, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lundin</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Idahl</LastName>
<ForeName>Annika</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden. Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Travis</LastName>
<ForeName>Ruth C</ForeName>
<Initials>RC</Initials>
<AffiliationInfo><Affiliation>Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Khaw</LastName>
<ForeName>Kay-Tee</ForeName>
<Initials>KT</Initials>
<AffiliationInfo><Affiliation>Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rinaldi</LastName>
<ForeName>Sabina</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Biomarkers Group, International Agency for Research on Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Romieu</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Biomarkers Group, International Agency for Research on Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Merritt</LastName>
<ForeName>Melissa A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gunter</LastName>
<ForeName>Marc J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Riboli</LastName>
<ForeName>Elio</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kaaks</LastName>
<ForeName>Rudolf</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fortner</LastName>
<ForeName>Renée T</ForeName>
<Initials>RT</Initials>
<AffiliationInfo><Affiliation>Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. r.fortner@dkfz-heidelberg.de.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>A14136</GrantID>
<Agency>Cancer Research UK</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant><GrantID>C570/A16491</GrantID>
<Agency>Cancer Research UK</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant><GrantID>G1000143</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant><GrantID>G0401527</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant><GrantID>14136</GrantID>
<Agency>Cancer Research UK</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>04</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Cancer Epidemiol Biomarkers Prev</MedlineTA>
<NlmUniqueID>9200608</NlmUniqueID>
<ISSNLinking>1055-9965</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2013 Nov 15;19(22):6074-83</RefSource>
<PMID Version="1">23958744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2010 Dec;21(12):2241-8</RefSource>
<PMID Version="1">20924664</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>ISRN Oncol. 2013 May 30;2013:697521</RefSource>
<PMID Version="1">23819063</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Gynecol Pathol. 2012 Nov;31(6):507-16</RefSource>
<PMID Version="1">23018221</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2014 Apr 2;110(7):1878-90</RefSource>
<PMID Version="1">24518590</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Obstet Gynecol. 2007 Apr;109(4):933-41</RefSource>
<PMID Version="1">17400857</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Public Health Nutr. 2002 Dec;5(6B):1113-24</RefSource>
<PMID Version="1">12639222</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2014 Apr;25(4):533-9</RefSource>
<PMID Version="1">24504436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hum Reprod Update. 2014 Sep-Oct;20(5):748-58</RefSource>
<PMID Version="1">24688118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hum Pathol. 2011 Jul;42(7):918-31</RefSource>
<PMID Version="1">21683865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Endocrinol. 2004 Feb;150(2):161-71</RefSource>
<PMID Version="1">14763914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(4):e36062</RefSource>
<PMID Version="1">22558327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1999 Sep 1;91(17):1459-67</RefSource>
<PMID Version="1">10469746</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Inflammation. 2011 Jun;34(3):161-70</RefSource>
<PMID Version="1">20467889</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Front Biosci (Elite Ed). 2013;5:461-78</RefSource>
<PMID Version="1">23277002</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Endocrinol. 2013;2013:678159</RefSource>
<PMID Version="1">23690772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Oct;1831(10):1533-41</RefSource>
<PMID Version="1">23500888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Obesity (Silver Spring). 2010 Aug;18(8):1625-31</RefSource>
<PMID Version="1">20035276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol. 2011 Oct;35(5):432-7</RefSource>
<PMID Version="1">21288792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2011 Aug;22(8):1916-21</RefSource>
<PMID Version="1">21292643</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cytokine. 2012 Aug;59(2):228-36</RefSource>
<PMID Version="1">22595649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Obes Relat Metab Disord. 2004 Aug;28(8):993-7</RefSource>
<PMID Version="1">15211360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Surg Pathol. 2010 Mar;34(3):433-43</RefSource>
<PMID Version="1">20154587</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Cell Endocrinol. 2006 Mar 9;247(1-2):4-21</RefSource>
<PMID Version="1">16297528</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2009 Feb;20(1):15-26</RefSource>
<PMID Version="1">18704713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Obes Res. 2003 Sep;11(9):1055-64</RefSource>
<PMID Version="1">12972675</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2010 May 15;126(10):2404-15</RefSource>
<PMID Version="1">19821492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Fertil Steril. 2002 Jan;77(1):128-35</RefSource>
<PMID Version="1">11779602</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2010 Dec;21(12):2183-94</RefSource>
<PMID Version="1">20827504</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2014 Nov;135(2):297-304</RefSource>
<PMID Version="1">25158036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hum Reprod. 2003 Aug;18(8):1681-5</RefSource>
<PMID Version="1">12871882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2004 Aug;4(8):579-91</RefSource>
<PMID Version="1">15286738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2010 Feb 3;102(3):202-6</RefSource>
<PMID Version="1">20056955</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2007 Jul;17(4):120-4</RefSource>
<PMID Version="1">17641447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2009 Dec;29(12):5229-34</RefSource>
<PMID Version="1">20044641</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Gynecol Cancer. 2009 Jan;19(1):58-64</RefSource>
<PMID Version="1">19258943</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2014 Apr 15;134(8):1947-57</RefSource>
<PMID Version="1">24155248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):98-107</RefSource>
<PMID Version="1">15668482</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):381-4</RefSource>
<PMID Version="1">16492932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2011 Sep;12(9):900-4</RefSource>
<PMID Version="1">21835693</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Histopathology. 2013 Jan;62(1):44-58</RefSource>
<PMID Version="1">23240669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):799-810</RefSource>
<PMID Version="1">21467242</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Endocr Relat Cancer. 2010 Dec;17(4):1007-19</RefSource>
<PMID Version="1">20843938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2009 Sep;20(7):1151-9</RefSource>
<PMID Version="1">19301134</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2014 Aug 28;33(35):4396-406</RefSource>
<PMID Version="1">24531714</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1998 Jun 1;147(11):1071-80</RefSource>
<PMID Version="1">9620051</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1993 Dec 1;138(11):923-36</RefSource>
<PMID Version="1">8256780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2013 Oct 15;178(8):1256-64</RefSource>
<PMID Version="1">23966559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Obstet Gynaecol Can. 2014 Feb;36(2):133-40</RefSource>
<PMID Version="1">24518912</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Endocr Relat Cancer. 2013 Apr;20(2):251-62</RefSource>
<PMID Version="1">23404857</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2013 Dec;24 Suppl 10:x16-21</RefSource>
<PMID Version="1">24265397</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D018262" MajorTopicYN="N">Adenocarcinoma, Clear Cell</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002288" MajorTopicYN="N">Adenocarcinoma, Mucinous</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018284" MajorTopicYN="N">Cystadenocarcinoma, Serous</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016889" MajorTopicYN="N">Endometrial Neoplasms</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">EMS62886</OtherID>
<OtherID Source="NLM">PMC4454588</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>11</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>03</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>4</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>4</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25855626</ArticleId>
<ArticleId IdType="pii">1055-9965.EPI-14-1279-T</ArticleId>
<ArticleId IdType="doi">10.1158/1055-9965.EPI-14-1279-T</ArticleId>
<ArticleId IdType="pmc">PMC4454588</ArticleId>
<ArticleId IdType="mid">EMS62886</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D28 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002D28 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:25855626
   |texte=   Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:25855626" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.

Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki